Nikhil Khushalani MD

Dr. Nikhil Khushalani is the Vice Chair for the Department of Cutaneous Oncology at Moffitt Cancer Center. Dr. Khushalani’s clinical interest is the development of novel therapeutics for people diagnosed with melanoma and other skin cancers. He is greatly interested in the treatment of uveal melanoma and melanoma that has metastasized to the brain. Dr. Khushalani is interested in research on angiogenesis in melanoma and the translation of findings into clinical therapeutics. He is studying the economic impact of new melanoma drugs on healthcare (pharmacoeconomics) with an aim to devise strategies to reduce costs.

Dr. Khushalani earned his MD from Topiwala National Medical College, University of Bombay, in Maharashtra, India. He completed an Internal Medicine Residency at the State University of New York (SUNY) at Buffalo, where he also served as Chief Resident. He completed a Medical Oncology Fellowship at Roswell Park Cancer Institute in 2002. Dr. Khushalani was Assistant Professor of Oncology at Roswell Park Cancer Institute and, prior to joining the Moffitt team, was Associate Professor of Medicine at SUNY, Buffalo, where he was the Section Chief of Soft Tissue and Melanoma Medicine, and Director of the IL-2 Program.